Biotricity Extends Heart Rate Variability Research to Include Fetal and Maternal Applications
October 23, 2018 at 08:00 am
Share
Biotricity Inc. announced that it will be expanding the scope of a previously approved clinical investigation of fetal heart rate variability (fHRV) to include maternal HRV and other key physiologic metrics for maximum predictive accuracy and efficiency. This extension aligns well with the company's ongoing research into clinical HRV and continues to leverage its strategic relationships to conduct innovative collaborative research without losing intellectual property (IP) or incurring additional costs. HRV is a measure of the variation in time between each heartbeat. A high HRV is a good indicator of greater cardiovascular fitness and resilience to stress, and thus a good indicator of overall health. It can also be used to differentiate between stable patients and those who may develop complications. Biotricity has observed and validated this capability in its initial clinical HRV study in the adult population, and it is well established in the delivery suite as well. A mobile, wireless and non-invasive maternal monitoring solution that incorporates HRV metrics will allow for real-time and real-life evaluation of both maternal and fetal health, which is especially important for higher-risk pregnancies.
Biotricity Inc. is a medical technology company focused on biometric data monitoring and diagnostic solutions. The Company developed its Bioflux technology, comprised of a monitoring device and software components. The Bioflux device is comprised of a wet electrode worn on a belt clip around the waist. The Bioflux ECG reporting software enables doctors and labs to view a patientâs electrocardiogram (ECG) data for monitoring and diagnostic purposes. Its Bioflux platform has a built-in cellular chipset and a real-time embedded operating system, which allows for its technology to be utilized as an Internet of Things (IoT) platform. It has developed several technologies, including Biotres, Bioheart, and Biocare. Biotres is an ECG Holter solution that addresses the limitations of existing solutions in the Holter market. Bioheart is a personal cardiac monitoring solution for consumers. Biocare is a cardiac disease management platform for chronic care management and remote patient monitoring.